Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LFC
3751
PUT
DELISTED
China Life Insurance Company Ltd.
LFC
| $864K | ﹤0.01% |
62,500
| – | – |
|
3752
CALL
Entergy
ETR
$49.8B
| $863K | ﹤0.01% |
14,400
-72,000
| -83% | -$4.24M |
|
|
CNST
3753
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $863K | ﹤0.01% |
18,336
+10,616
| +138% | +$306K |
|
3754
PUT
Invesco
IVZ
$14.3B
| $862K | ﹤0.01% |
47,900
-45,400
| -49% | -$774K |
|
|
CSR
3755
Centerspace
CSR
$942M
| $861K | ﹤0.01% |
11,882
+5,895
| +98% | +$440K |
|
3756
PUT
MPLX
MPLX
$60.8B
| $861K | ﹤0.01% |
33,800
+15,000
| +80% | +$382K |
|
3757
Cable One
CABO
$247M
| $858K | ﹤0.01% |
577
-1,257
| -69% | -$1.78M |
|
3758
American Public Education
APEI
$951M
| $857K | ﹤0.01% |
31,260
+3,412
| +12% | +$83.4K |
|
3759
Fidelity MSCI Financials Index ETF
FNCL
$2.42B
| $857K | ﹤0.01% |
19,300
| – | – |
|
|
TSC
3760
DELISTED
TriState Capital Holdings, Inc.
TSC
| $857K | ﹤0.01% |
32,805
+20,764
| +172% | +$494K |
|
3761
Brunswick
BC
$5.37B
| $854K | ﹤0.01% |
14,221
+5,052
| +55% | +$292K |
|
3762
HUTCHMED
HCM
$2.02B
| $854K | ﹤0.01% |
34,061
+16,917
| +99% | +$370K |
|
3763
Rogers Communications
RCI
$18.5B
| $854K | ﹤0.01% |
17,190
-40,035
| -70% | -$1.93M |
|
3764
ANI Pharmaceuticals
ANIP
$1.87B
| $852K | ﹤0.01% |
13,813
+4,626
| +50% | +$306K |
|
3765
Green Plains
GPRE
$1.08B
| $852K | ﹤0.01% |
55,245
-7,489
| -12% | -$102K |
|
|
OPB
3766
DELISTED
Opus Bank Common Stock
OPB
| $851K | ﹤0.01% |
32,894
+11,207
| +52% | +$277K |
|
|
NPKI
3767
NPK International
NPKI
$1.17B
| $850K | ﹤0.01% |
135,412
+31,413
| +30% | +$205K |
|
|
WTRE
3768
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $850K | ﹤0.01% |
33,799
+19,388
| +135% | +$515K |
|
3769
Select Water Solutions
WTTR
$2.62B
| $849K | ﹤0.01% |
91,409
+29,493
| +48% | +$238K |
|
|
LL
3770
CALL
DELISTED
LL Flooring Holdings, Inc.
LL
| $849K | ﹤0.01% |
86,900
-13,000
| -13% | -$122K |
|
3771
Denali Therapeutics
DNLI
$3.92B
| $848K | ﹤0.01% |
48,668
+4,218
| +9% | +$70.2K |
|
3772
Upland Software
UPLD
$12.8M
| $848K | ﹤0.01% |
2,378
+1,228
| +107% | +$459K |
|
3773
Alector
ALEC
$173M
| $846K | ﹤0.01% |
49,063
+23,466
| +92% | +$399K |
|
3774
Barrett Business Services
BBSI
$828M
| $846K | ﹤0.01% |
37,416
+12,548
| +50% | +$278K |
|
3775
PUT
Blackbaud
BLKB
$2.04B
| $844K | ﹤0.01% |
10,600
-32,000
| -75% | -$2.68M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.